At-home Genetic Testing Market

The at-home genetic testing market was valued at $2,193.45 million in 2023 and is estimated to reach $20,161.74 million by 2035, exhibiting a CAGR of 20.3% from 2024 to 2035. At-home genetic testing refers to a consumer-accessible method for analyzing genetic information using a sample, typically saliva or a cheek swab, collected at home and sent to a laboratory for analysis. The mechanism of action involves DNA extraction from the provided sample, followed by amplification using polymerase chain reaction (PCR) or sequencing technologies like Next-Generation Sequencing (NGS) or microarrays to identify genetic variations, mutations, or predispositions to certain traits or diseases.

The processed data is then interpreted and delivered to the consumer through an online portal or a report. The advantages of at-home genetic testing include convenience, as it eliminates the need for clinic visits; accessibility, allowing individuals to explore their genetic makeup without medical referrals; and personalized insights into ancestry, health risks, and potential drug responses. Additionally, some tests offer actionable health recommendations, enabling early interventions and lifestyle modifications to manage genetic predispositions effectively. One of the primary drivers of the at-home genetic testing market is the growing incidence of genetic disorders and chronic diseases such as cancer, cardiovascular diseases, and diabetes. Many of these conditions have a hereditary component, prompting individuals to seek genetic testing to determine their risk. The rise in prevalence of cancer is a major factor contributing to the growth of the at-home genetic testing market. According to the World Health Organization (WHO), cancer cases are projected to reach 35 million by 2050, marking a 77% increase from 20 million cases in 2022.

This growing incidence of cancer increased the demand for diagnostic options, including at-homegenetic testing. In addition, consumers are becoming more proactive about their health, seeking preventive care solutions and personalized medical insights, which thereby drives the demand for genetic testing. At-home genetic testing allows individuals to understand their genetic predisposition to various conditions and make informed lifestyle and healthcare decisions. Personalized medicine is gaining traction, with genetic testing helping tailor treatments based on a person’s unique genetic makeup. For instance, pharmacogenomic testing helps determine how an individual responds to certain medications, optimizing drug efficacy and reducing adverse effects. However, the lack of standardized regulations across different countries creates uncertainty in the market. Another significant limitation is the accuracy and reliability of at-home genetic tests compared to clinical genetic testing. Many at-home tests provide limited interpretations and may not account for environmental or lifestyle factors, leading to misleading or inconclusive results thereby restricting the market growth.

On the other hand, rise in technological advancements in genetic testing, increase in consumer awareness, and the rise in demand for personalized healthcare provides an opportunity for market growth. The expansion of direct-to consumer (DTC) genetic testing allows companies to reach a broader audience, offering tests for disease risk assessment, ancestry, nutrition, fitness, and pharmacogenomics. The at-home genetic testing market is segmented into type, application, and region. By type, the market is segmented into carrier test, nutrigenomics test, predictive and presymptomatic test, ancestry, and others. By application, the market is segregated into cancer diagnosis, genetic disease diagnosis, ancestry, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

Major key players that operate in the global at-home genetic testing market are Myriad Genetics, Inc., Ancestry, Gene by Gene, Ltd., MyHeritage Ltd., Prenetics Global Limited, Color Health, Inc., Living DNA Ltd., 23andMe Holding Co., Rhythm Biosciences, and Mapmygenome. Key players operating in the market have adopted product launch and partnership as their key strategies to expand their product portfolio. For instance, in May 2024, Color Health announced partnerships with SkinIO and Bexa to integrate their distributed solutions for skin cancer screening and breast cancer early detection into Color's Virtual Cancer Clinic. With the addition of new, innovative screening technologies, Color is building on its program for employers to significantly increase cancer screening and detection rates and manage cancer holistically. Through Bexa, examinations for breast cancer can be conveniently accessible at worksites across all 50 U.S. states, and with SkinIO, screenings for skin cancer are available to anyone with a smartphone.

Key Benefits for Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the at-home genetic testing market analysis from 2023 to 2035 to identify the prevailing at-home genetic testing market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the at-home genetic testing market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global at-home genetic testing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Application

Cancer Diagnosis
Genetic Disease Diagnosis
Ancestry
Others

By Type

Carrier Test
Predictive and Presymptomatic Testing
Nutrigenomics Testing
Ancestry
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
Myriad Genetics, Inc.
Ancestry
MyHeritage Ltd.
Color Health, Inc.
Living DNA Ltd.
Gene by Gene, Ltd.
Prenetics Global Limited
23andMe Holding Co.
Rhythm Biosciences
MapmygenomeThe research methodology of the global market involves extensive primary and secondary research. Primary research includes about over 12 hours of interviews and discussion with a wide range of stakeholders, including upstream and downstream participants. The primary research typically is the bulk of our research efforts; however, coherently supported by extensive secondary research. Researchers have reviewed over 6,765 product literatures, industry releases, annual reports, and other such documents of key industry participants to obtain better market understanding and gain competitive intelligence. In addition, authentic industry journals, trade associations' releases,and government websites have also been reviewed for generating high-value industry insights.